Stephen Zohar Sack, MD | |
11212 E 48th St, Tulsa, OK 74146-5824 | |
(918) 497-3715 | |
(918) 884-7282 |
Full Name | Stephen Zohar Sack |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 22 Years |
Location | 11212 E 48th St, Tulsa, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548319940 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | MT182252 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Radiation Therapy Specialists Of Tulsa, Pllc | 7517033475 | 2 |
News Archive
One of the benefits to cutting fossil fuel consumption is lowering air pollution. A new study in the August issue of Ecological Indicators shows that, on average, an increase in pollution particles in the air of 10 micrograms per cubic meter cuts victims' life expectancy by 9-11 years - more than previously thought.
A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a -20million grant from the Wolfson Foundation, it was announced today.
It is estimated that rare diseases -those whose frequency is under 5 cases / 10,000 people- affect about 6% of the European population. In the field of anemia, 1% of couples are at risk of having a newborn with a severe syndrome of hemoglobin. More than 330,000 children are born worldwide each year affected by one of these diseases, being the most common disorders sickle cell anemia and thalassemia syndromes.
Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for ZUTRIPRO Oral Solution (CIII) and REZIRA Oral Solution.
› Verified 6 days ago
Entity Name | Radiation Therapy Specialists Of Tulsa, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598927618 PECOS PAC ID: 7517033475 Enrollment ID: O20080829000393 |
News Archive
One of the benefits to cutting fossil fuel consumption is lowering air pollution. A new study in the August issue of Ecological Indicators shows that, on average, an increase in pollution particles in the air of 10 micrograms per cubic meter cuts victims' life expectancy by 9-11 years - more than previously thought.
A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a -20million grant from the Wolfson Foundation, it was announced today.
It is estimated that rare diseases -those whose frequency is under 5 cases / 10,000 people- affect about 6% of the European population. In the field of anemia, 1% of couples are at risk of having a newborn with a severe syndrome of hemoglobin. More than 330,000 children are born worldwide each year affected by one of these diseases, being the most common disorders sickle cell anemia and thalassemia syndromes.
Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for ZUTRIPRO Oral Solution (CIII) and REZIRA Oral Solution.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Stephen Zohar Sack, MD 11212 E 48th St, Tulsa, OK 74146-5824 Ph: (918) 497-3715 | Stephen Zohar Sack, MD 11212 E 48th St, Tulsa, OK 74146-5824 Ph: (918) 497-3715 |
News Archive
One of the benefits to cutting fossil fuel consumption is lowering air pollution. A new study in the August issue of Ecological Indicators shows that, on average, an increase in pollution particles in the air of 10 micrograms per cubic meter cuts victims' life expectancy by 9-11 years - more than previously thought.
A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a -20million grant from the Wolfson Foundation, it was announced today.
It is estimated that rare diseases -those whose frequency is under 5 cases / 10,000 people- affect about 6% of the European population. In the field of anemia, 1% of couples are at risk of having a newborn with a severe syndrome of hemoglobin. More than 330,000 children are born worldwide each year affected by one of these diseases, being the most common disorders sickle cell anemia and thalassemia syndromes.
Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for ZUTRIPRO Oral Solution (CIII) and REZIRA Oral Solution.
› Verified 6 days ago
Jonathan Cross, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5801 E 41st St Ste 900, Tulsa, OK 74135 Phone: 918-747-4975 Fax: 918-743-8552 | |
Dr. Kim R Hauger, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5801 E 41st St Ste 900, Tulsa, OK 74135 Phone: 918-747-4975 Fax: 918-743-8552 | |
Nina Jones, MD Radiology Medicare: Medicare Enrolled Practice Location: 4500 S Garnett Rd Ste 300, Tulsa, OK 74146 Phone: 918-728-6194 | |
Dr. Leila Danielle See, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 744 W 9th St, Tulsa, OK 74127 Phone: 981-599-5031 | |
Christopher Roman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4500 S Garnett Rd Ste 112, Tulsa, OK 74146 Phone: 918-935-3550 | |
Dr. Phillip Osborn Flinn, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1120 S Utica Ave, Tulsa, OK 74104 Phone: 918-934-8347 Fax: 918-917-4114 | |
Shawn D Grant, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1120 S Utica Ave, Tulsa, OK 74104 Phone: 918-579-7720 |